Organism name | Senecio nemorensis |
---|---|
Genus | Senecio |
Family | Asteraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Senecio nemorensis |
---|---|
Linked NCBI taxonomy ID | 189242 |
Linked level | species |
Family in NCBI taxonomy | Asteraceae |
---|---|
ID | 4210 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
Species | Activity |
---|---|
Senecio nemorensis L. | Carcinogenic |
Senecio nemorensis L. | Hemostat |
Senecio nemorensis L. | Hepatotoxic |
Senecio nemorensis L. | Hypoglycemic |
Senecio nemorensis L. | Hypotensive |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005413
![]() |
Rutin
/ Birutan / 3-Rutinosylquercetin / Quercetin 3-O-rutinoside / (+)-Quercetin 3-O-rutinoside / Quercetin 3-O-beta-rutinoside / (+)-Quercetin 3-O-beta-rutinoside / 3,3',4',5,7-Pentahydroxyflavone 3-rutinoside / Quercetin 3-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside |
CHEMBL32579
CHEMBL310754 CHEMBL182108 CHEMBL226335 CHEMBL502782 CHEMBL1436093 CHEMBL1532989 |
D012431
|
25 / 18 / 16 | 29 / 8 | No. 1 | No. 15 |
![]() |
C00005374
![]() |
Quercetin
|
CHEMBL82242
CHEMBL479232 CHEMBL1437696 |
C012526
|
14 / 2 / 2 | 2 / 1 | No. 2 | No. 15 |
![]() |
C00002724
![]() |
Heriguard
/ Chlorogenic acid / 3-O-Caffeoylquinic acid |
CHEMBL284616
CHEMBL230481 CHEMBL249450 CHEMBL1332980 CHEMBL1394423 CHEMBL1419611 CHEMBL1473644 CHEMBL1552319 |
D002726
|
30 / 19 / 22 | 37 / 9 | No. 314 | No. 6 |
![]() |
C00017393
![]() |
Senemorin
|
CHEMBL253986
|
No. 785 |
![]() |
||||
C00002670
![]() |
Pyrogallol
|
CHEMBL307145
|
D011748
|
115 / 69 / 60 | 8 / 2 | No. 1590 | No. 82 |
![]() |
C00017394
![]() |
10alpha-Furanoligularenone
|
No. 2598 |
![]() |
|||||
C00002102
![]() |
Nemorensine
|
CHEMBL507995
|
No. 2902 | No. 2 |
![]() |
|||
C00001183
![]() |
Fumaric acid
|
CHEMBL503160
CHEMBL539648 |
C032005
|
17 / 14 / 46 | 0 / 1 | No. 3766 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001183 C00002670 C00002724 C00005374 C00005413 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002670 C00005374 C00005413 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00002670 C00002724 C00005374 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002670 C00002724 C00005413 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002724 C00005374 C00005413 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002670 C00002724 C00005374 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002670 C00002724 C00005413 | 0 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002670 C00002724 C00005413 | 0 / 3 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001183 C00002724 C00005374 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001183 C00002670 C00002724 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00002670 C00002724 C00005413 | 3 / 3 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002670 C00002724 | 1 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00002670 C00002724 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002670 C00002724 | 1 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | C00002670 C00005413 | 1 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00002670 C00005413 | 1 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00002670 C00002724 | 2 / 2 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002670 C00002724 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002670 C00005413 | 0 / 0 |
P14679 | Tyrosinase | Oxidoreductase | C00002670 C00005413 | 4 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00002670 C00002724 | 0 / 1 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001183 C00002670 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00002670 C00002724 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00001183 C00002724 | 3 / 2 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00005374 C00005413 | 1 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001183 C00002670 | 1 / 2 |
P15121 | Aldose reductase | Enzyme | C00002724 C00005374 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00002670 C00005413 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001183 C00002724 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00002670 C00002724 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002670 C00002724 | 0 / 1 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00002670 C00005413 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00002670 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00002670 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00002670 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00002670 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00002670 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00002670 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00002670 | 1 / 0 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005374 | 0 / 0 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00001183 | 1 / 1 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00005413 | 1 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002670 | 1 / 8 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00005413 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00002670 | 2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00002670 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002670 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00002670 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00002670 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00002670 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00002670 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00002670 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00002670 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00002670 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00002670 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00002670 | 1 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00002670 | 0 / 0 |
P16581 | E-selectin | Adhesion | C00002670 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002670 | 0 / 0 |
Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Hydroxycarboxylic acid receptor | C00001183 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00005374 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00002670 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00002724 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00002670 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00002670 | 0 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00002670 | 1 / 1 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00002670 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00002670 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00002670 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00002670 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00002670 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00002670 | 0 / 0 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00002670 | 0 / 1 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00002670 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00002670 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00002670 | 11 / 10 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00002670 | 1 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00002670 | 2 / 2 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00002670 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00002670 | 0 / 0 |
P27487 | Dipeptidyl peptidase 4 | S9B | C00005413 | 0 / 1 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00002670 | 1 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00002724 | 1 / 2 |
P03956 | Interstitial collagenase | M10A | C00002670 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00002670 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00005374 | 1 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00005374 | 0 / 0 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00001183 | 1 / 2 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001183 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00005413 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00002670 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002670 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002670 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00002670 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00002670 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00002670 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00002670 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002670 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00002670 | 0 / 0 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | C00002724 | 0 / 0 |
P06276 | Cholinesterase | Hydrolase | C00005413 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00002670 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00002670 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00002670 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00002670 | 1 / 0 |
P29466 | Caspase-1 | C14 | C00002670 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00002670 | 2 / 1 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001183 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001183 | 0 / 0 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00005413 | 2 / 0 |
P51692 | Signal transducer and activator of transcription 5B | Unclassified protein | C00002724 | 1 / 1 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00002670 | 2 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001183 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00002670 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00005413 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00002670 | 1 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00002670 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002670 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00002670 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00002670 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002670 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00002670 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00002670 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00002670 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002670 | 0 / 0 |
P14151 | L-selectin | Adhesion | C00002670 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00002670 | 1 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00005413 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00002670 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00002670 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00005374 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002724 | 3 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00002670 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00002670 | 5 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00005413 | 4 / 3 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00002724 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00002670 | 2 / 1 |
P10275 | Androgen receptor | NR3C4 | C00002670 | 3 / 4 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00002670 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00002670 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00002670 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00002670 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00002670 | 1 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002670 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00002670 | 0 / 0 |
P48147 | Prolyl endopeptidase | S9A | C00005413 | 0 / 0 |
O60218 | Aldo-keto reductase family 1 member B10 | Enzyme | C00002724 | 0 / 0 |
Q16798 | NADP-dependent malic enzyme, mitochondrial | Enzyme | C00001183 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00002670 | 0 / 0 |
P42224 | Signal transducer and activator of transcription 1-alpha/beta | Unclassified protein | C00002724 | 3 / 3 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | C00005374 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001183 | 7 / 37 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002670 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002670 | 1 / 4 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00005413 | 0 / 0 |
Q9C0B1 | Alpha-ketoglutarate-dependent dioxygenase FTO | Unclassified protein | C00001183 | 1 / 2 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00005374
C00005413
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00005374
C00005413
|
847 | CAT | catalase (EC:1.11.1.6) |
C00002670
C00005413
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002670
C00005413
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00005413
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00002724
|
960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00002724
|
999 | CDH1, Arc-1, CD324, CDHE, ECAD, LCAM, UVO | cadherin 1, type 1, E-cadherin (epithelial) |
C00002724
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00002724
|
4512 | COX1, COI, MTCO1, MT-CO1 | cytochrome c oxidase subunit I |
C00002724
|
114757 | CYGB, HGB, STAP | cytoglobin |
C00002724
|
1830 | DSG3, CDHF6, PVA | desmoglein 3 |
C00002724
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00002724
|
2200 | FBN1, ACMICD, ECTOL1, FBN, GPHYSD2, MASS, MFS1, OCTD, SGS, SSKS, WMS, WMS2 | fibrillin 1 |
C00002724
|
2201 | FBN2, CCA, DA9 | fibrillin 2 |
C00002724
|
2246 | FGF1, AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-1, FGF-alpha, FGFA, GLIO703, HBGF-1, HBGF1 | fibroblast growth factor 1 (acidic) |
C00002724
|
2896 | GRN, CLN11, GEP, GP88, PCDGF, PEPI, PGRN | granulin |
C00002724
|
3036 | HAS1, HAS | hyaluronan synthase 1 (EC:2.4.1.212) |
C00002724
|
3315 | HSPB1, CMT2F, HMN2B, HS.76067, HSP27, HSP28, Hsp25, SRP27 | heat shock 27kDa protein 1 |
C00002724
|
3552 | IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1 | interleukin 1, alpha |
C00002724
|
3852 | KRT5, CK5, DDD, DDD1, EBS2, K5, KRT5A | keratin 5 |
C00002724
|
4157 | MC1R, CMM5, MSH-R, SHEP2 | melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
C00002724
|
4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00002724
|
5241 | PGR, NR3C3, PR | progesterone receptor |
C00002724
|
8985 | PLOD3, LH3 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (EC:1.14.11.4) |
C00002724
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00002724
|
5886 | RAD23A, HHR23A, HR23A | RAD23 homolog A (S. cerevisiae) |
C00002724
|
5914 | RARA, NR1B1, RAR | retinoic acid receptor, alpha |
C00002724
|
6256 | RXRA, NR2B1 | retinoid X receptor, alpha |
C00002724
|
6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00002724
|
6716 | SRD5A2 | steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (EC:1.3.1.22) |
C00002724
|
7178 | TPT1, HRF, TCTP, p02, p23 | tumor protein, translationally-controlled 1 |
C00002724
|
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00002724
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00002724
|
7306 | TYRP1, CAS2, CATB, GP75, OCA3, TRP, TRP1, TYRP, b-PROTEIN | tyrosinase-related protein 1 (EC:1.14.18.-) |
C00002724
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002724
|
54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002724
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002724
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002724
|
351 | APP, AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2 | amyloid beta (A4) precursor protein |
C00002670
|
358 | AQP1, AQP-CHIP, CHIP28, CO | aquaporin 1 |
C00002724
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00002670
|
47 | ACLY, ACL, ATPCL, CLATP | ATP citrate lyase (EC:2.3.3.8) |
C00002724
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00002670
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00002670
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00002670
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00002670
|
177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00005413
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00005413
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00005413
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00005413
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00005413
|
873 | CBR1, CBR, SDR21C1, hCBR1 | carbonyl reductase 1 (EC:1.1.1.189 1.1.1.197 1.1.1.184) |
C00005413
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00005413
|
360 | AQP3, AQP-3, GIL | aquaporin 3 (Gill blood group) |
C00002724
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00005413
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00005413
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00005413
|
3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00005413
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00005413
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00005413
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00005413
|
3667 | IRS1, HIRS-1 | insulin receptor substrate 1 |
C00005413
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00005413
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00005413
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00005413
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00005413
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00005413
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00005413
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00005413
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00005413
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00005413
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#600807 | Asthma, susceptibility to |
Q13093
|
#209950 | Atypical mycobacteriosis, familial |
P42224
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#614162 | Candidiasis, familial, 7; candf7 |
P42224
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#218800 | Crigler-najjar syndrome, type i |
P22309
|
#606785 | Crigler-najjar syndrome, type ii |
P22309
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#612219 | Ewing sarcoma; es |
P11308
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#232300 | Glycogen storage disease ii |
P10253
|
#245590 | Growth hormone insensitivity with immunodeficiency |
P51692
|
#612938 | Growth retardation, developmental delay, coarse facies, and early death; gdfd |
Q9C0B1
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#613796 | Mycobacterial and viral infections, susceptibility to, autosomal recessive |
P42224
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P16109
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P27487 (marker) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
P11308 (related) |
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00089 | IFN-gamma/IL-12 axis |
P42224
(related)
|
H00363 | Candidiasis |
P42224
(related)
|
H01109 | Chronic mucocutaneous candidiasis (CMC) |
P42224
(related)
|
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00931 | Growth hormone insensitivity with immunodeficiency |
P51692
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00409 | Type II diabetes mellitus |
Q9C0B1
(related)
|
H00926 | Growth retardation, developmental delay, coarse facies, and early death |
Q9C0B1
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D056486 | Drug-Induced Liver Injury |
C00002724
C00002670 |
D015431 | Weight Loss |
C00002724
|
D000647 | Amnesia |
C00002724
|
D010146 | Pain |
C00005374
|
D006937 | Hypercholesterolemia |
C00002724
|
D006951 | Hyperlipoproteinemias |
C00002724
|
D015228 | Hypertriglyceridemia |
C00002724
|
D052456 | Hypoalphalipoproteinemias |
C00002724
|
D008545 | Melanoma |
C00002724
|
D009336 | Necrosis |
C00002724
|
D002471 | Cell Transformation, Neoplastic |
C00001183
|
D048629 | Micronuclei, Chromosome-Defective |
C00002670
|
D001424 | Bacterial Infections |
C00005413
|
D003092 | Colitis |
C00005413
|
D004409 | Dyskinesia, Drug-Induced |
C00005413
|
D015212 | Inflammatory Bowel Diseases |
C00005413
|
D007674 | Kidney Diseases |
C00005413
|
D028361 | Mitochondrial Diseases |
C00005413
|
D010243 | Paralysis |
C00005413
|
D013276 | Stomach Ulcer |
C00005413
|